EUVIMEDEUVIMED entdecken
Crossref

Reply to: “On the Distinction Between Prognostic and Predictive Inference in Multicancer Early Detection” and “Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution”

Charles Swanton iD

JCO Precision Oncology · 2026-06 · 10 (6)

DOI: 10.1200/po-26-00523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Precision Oncology, 2026-06. Verfasst von Charles Swanton. Beteiligte Einrichtung: Charles Swanton, PhD, MBBS, Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Charles Swanton, PhD, MBBS, Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.

ORCID-Profile: Charles Swanton

Zitieren

APA

Swanton, C. (2026). Reply to: “On the Distinction Between Prognostic and Predictive Inference in Multicancer Early Detection” and “Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution”. JCO Precision Oncology, 10(6). https://doi.org/10.1200/po-26-00523

Vancouver

Swanton C. Reply to: “On the Distinction Between Prognostic and Predictive Inference in Multicancer Early Detection” and “Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution”. JCO Precision Oncology. 2026;10(6). doi:10.1200/po-26-00523

BibTeX
@article{Swanton2026,
  author = {Swanton, Charles},
  title = {Reply to: “On the Distinction Between Prognostic and Predictive Inference in Multicancer Early Detection” and “Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution”},
  journal = {JCO Precision Oncology},
  year = {2026},
  volume = {10},
  number = {6},
  doi = {10.1200/po-26-00523}
}
Kostenlos starten →